Role of natural killer cells in innate protection against lethal ebola virus infection. - Wikidata - awgldk - TriplyDB

Role of natural killer cells in innate protection against lethal ebola virus infection.

Role of natural killer cells in innate protection against lethal ebola virus infection.

http://www.wikidata.org/entity/Q36399839

about

Effective post-exposure treatment of Ebola infection Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.Mouse models for filovirus infections Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections.Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talk.Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins Differential regulation of GM1 and asialo-GM1 expression by T cells and natural killer (NK) cells in respiratory syncytial virus infection Molecular mechanisms of Ebola virus pathogenesis: focus on cell death.EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies.Oxidative stress and ageing: is ageing a cysteine deficiency syndrome?Mechanisms of immunity in post-exposure vaccination against Ebola virus infection.Evasion of the interferon-mediated antiviral response by filoviruses.Advances in virus-like particle vaccines for filoviruses.Filovirus vaccines.Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms.Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection.Progress in filovirus vaccine development: evaluating the potential for clinical use.Filovirus-like particles as vaccines and discovery tools.Natural killer cell-dendritic cell crosstalk in the initiation of immune responses.Natural killer cells in viral infection: more than just killers.B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses.Roles of natural killer cells in antiviral immunity Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway.Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation Protection against filovirus infection: virus-like particle vaccines.Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates Innate immune control and regulation of influenza virus infections.Natural Killer Cell Development and Maturation Revisited: Possible Implications of a Novel Distinct Lin-CD34+DNAM-1brightCXCR4+ Cell Progenitor.Correlates of immunity to filovirus infection.Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.Natural killer cells in hepatitis C virus infection.Characterization of a putative filovirus vaccine: virus-like particles.

P2860

Q21131616-10B794AE-0A61-4472-84AA-12A6906265AF Q21144780-0FEBA27C-940B-47F5-B8B0-8CCC8CE2F403 Q25256700-76276E29-0959-4C4E-BD76-C2556414857E Q27011569-CB579FCE-CCE2-486C-BE20-38C09350BFDE Q31152190-C7ACD672-6C85-4E1B-97E1-A0B9D48C1481 Q33803364-4AE66D36-84F1-4C9E-820C-ACA780735EDC Q33834018-D3FEE618-7FAF-4B13-BAC8-8ABB763603B4 Q34009337-2901EF89-4C75-4A6B-981C-5FF58A738659 Q34123838-5898FA3C-4B4A-4F46-92A8-DC02D3BAAFFF Q34186010-FCEA6962-8A96-47DA-B325-085D0E1A0B90 Q34478514-DAAF024F-86E0-4871-9824-EA33449093BE Q34488551-9339B0A3-FDB4-47CA-9971-B0D2AC088F16 Q34509643-57555228-F733-43BE-9C78-83D2DEA46FEC Q34583832-B42A8D0E-6156-4AC2-A669-2DD9B488D124 Q34971349-C04E2139-CE34-4550-9CC2-C425A145BB56 Q35038201-0663E18A-0CBE-4822-B931-A4B06FBAAB1E Q35192417-D3A70705-6EC1-4C47-B062-DA55288AAE64 Q35260239-0D7DADD3-CB8F-4E7A-A723-95C4A92B3471 Q35300029-918ADADB-94EF-4CEC-B4ED-8BB78B5AE872 Q35558539-B1611C54-362A-4CEC-9FD5-C7DD8A3450C3 Q35842390-4D914AEC-72D6-43D3-8476-7916A98B2602 Q35955731-BD99B9AE-A881-470F-A562-9BC24D088364 Q36086277-905CDDA0-B2CC-41B8-8F92-8FC51F578EEA Q36100545-3189FE5C-0997-4365-BF89-32F496CC1096 Q36198685-44BAF13E-BED8-4E61-A73B-58136C76AB78 Q36269618-667EFA54-6EFB-4A39-AC41-96AABB04AE76 Q36652221-A6DDA072-3A29-4EDA-9DD1-F7C97530AAE9 Q36675682-88DC371F-8E3F-4B7E-A51E-77100DB87391 Q36767761-73FF8238-E880-480D-A538-C66C2D5D349B Q36960705-91FA44B8-E470-4C59-9A73-9BFC50C24948 Q37031810-319FBDCE-0402-4302-805F-D5ED5D6F9E31 Q37130463-9FC299F7-B87C-4843-A07F-70211B18B3F9 Q37190830-8ADC9D88-AD19-4BAC-B352-742A638555AF Q37213207-A2A613E7-9C02-4D32-BFCC-A5C9D0AA2E11 Q37362928-C257AE0C-EB3E-40BB-A62C-0FCDB3F20E53 Q37689426-A175FB9F-8415-4A16-B6E3-FAEAF7E28F25 Q37945233-2DFD4358-16E4-4017-A9B0-51ED0A0367D5 Q37976671-F19231C2-8940-46D0-A51A-5FA0DD8209D1 Q38061192-AF65A5AC-DB7C-4DF3-AD6A-1E09814FD3F6 Q38079404-0971BDA4-BB84-4C99-850A-93F5C7F72FEB

P2860

Role of natural killer cells in innate protection against lethal ebola virus infection.

http://www.wikidata.org/entity/Q36399839

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Role of natural killer cells in innate protection against lethal ebola virus infection.

@ast

Role of natural killer cells in innate protection against lethal ebola virus infection.

@en

type

label

Role of natural killer cells in innate protection against lethal ebola virus infection.

@ast

Role of natural killer cells in innate protection against lethal ebola virus infection.

@en

prefLabel

Role of natural killer cells in innate protection against lethal ebola virus infection.

@ast

Role of natural killer cells in innate protection against lethal ebola virus infection.

@en

P1433

Q36399839-3CF4C08A-75D1-439C-BAB2-E920EC367D3D

P1476

Q36399839-07DB33F2-3BC5-44D3-83E7-E83EDD25060D

P2093

Q36399839-3860768D-5A83-4242-A5F4-47767EA8473F

Q36399839-4DC2F21E-A222-4C8E-B5DB-A86A4FB3F34D

Q36399839-A484C4A6-2627-4C10-A78A-41E669A1FA5E

Q36399839-B297BC2E-D310-478D-B8AD-5CC600C36F2A

Q36399839-B6CA50AE-E7BB-4504-AFBA-601F44E7C911

Q36399839-C5B23DCB-81D2-40A4-89C3-D885D549D99F

Q36399839-C9F5825F-7108-4EB4-8985-793A3410578C

Q36399839-FF7D31B5-23A0-4B09-AE9F-974252BA5F1E

P2860

Q36399839-018A6CAA-FE15-4C17-89F4-24D9632AD0CD

Q36399839-03C99B54-99E6-4DD7-B208-5B1E6C22BEBD

Q36399839-0745265C-8ABA-4115-AA6B-BF16E9C290C8

Q36399839-0FF874BB-94DF-4C93-9B85-9E72EA904635

Q36399839-100BE139-C0C5-4638-A18B-2AD03AB3D13D

Q36399839-108FE4B4-7FA1-42FB-8C4D-C1D6756622AE

Q36399839-137714BA-6B3F-4C75-94D9-EC78B7804C9C

Q36399839-2980D9A3-AE00-4AF6-B85A-6FD668955DE8

Q36399839-2DE83146-94F8-4AE8-8A9B-EC4D1051ADA9

Q36399839-2F2B790B-CB1C-470C-8D63-EC5D657561F4

P304

Q36399839-36671234-AC2F-415B-8A7F-A524D3F555DE

P31

Q36399839-74A75EAF-232B-4D72-A6A8-B027F4DCF18D

P356

Q36399839-94345BB4-F581-4513-A882-18B2B77E7D46

P407

Q36399839-414A3EF4-5544-484B-BAEC-EDD9C57031B6

P433

Q36399839-0D0519E1-40CD-480B-A8B1-79BBF242E61A

P478

Q36399839-4905DFF2-DF8F-4CD8-B584-53BEC1F6BAA6

P50

Q36399839-95236D65-7973-47CA-8B63-C5F14ED1E231

P577

Q36399839-E9D6868C-6D74-4AB4-9489-B5875AA3CA5F

P5875

Q36399839-5C759F35-A8A7-4645-A05A-5AC7CDC01EF2

P698

Q36399839-277F1911-59C2-47A6-AA09-D4D62E8FEEB4

P921

Q36399839-10D39086-CCF7-4208-A3FE-A46FA2A818C6

P932

Q36399839-4659FA55-B231-4A50-B21F-91AEF0D4CA2A

P356

P1433

Journal of Experimental Medicine

P1476

Role of natural killer cells in innate protection against lethal ebola virus infection.

@en

P2093

Catharine M Bosio

http://www.w3.org/2001/XMLSchema#string

Dana L Swenson

http://www.w3.org/2001/XMLSchema#string

Emily M Deal

http://www.w3.org/2001/XMLSchema#string

Howard A Young

http://www.w3.org/2001/XMLSchema#string

Jeremy G Perkins

http://www.w3.org/2001/XMLSchema#string

Kelly L Warfield

http://www.w3.org/2001/XMLSchema#string

M Javad Aman

http://www.w3.org/2001/XMLSchema#string

Wayne M Yokoyama

http://www.w3.org/2001/XMLSchema#string

P2860

The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties

Early immune responses accompanying human asymptomatic Ebola infections

In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding.

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells.

Natural killer cells in antiviral defense: function and regulation by innate cytokines.

The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis.

Ebola virus VP40-induced particle formation and association with the lipid bilayer.

Human asymptomatic Ebola infection and strong inflammatory response.

Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.

Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus

P304

169-179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20032141

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

200

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8458922

http://www.w3.org/2001/XMLSchema#string

P698

15249592

http://www.w3.org/2001/XMLSchema#string

P921

P932

2212007

http://www.w3.org/2001/XMLSchema#string